Trial · NCT01473602
Results by group38
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 38
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture | Teriparatide | 74 | 90% Confidence Interval 51 to 88 | Percentage of participants | |
| Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture | Placebo | 93 | 90% Confidence Interval 70 to 99 | Percentage of participants | |
| Percentage of Participants With Radiographic Evidence of Healing | Teriparatide | 55.6 | Percentage of participants | ||
| Percentage of Participants With Radiographic Evidence of Healing | Placebo | 65.0 | Percentage of participants | ||
| Percentage of Participants With Pain Control During Ambulation | Teriparatide | 90.0 | Percentage of participants | ||
| Percentage of Participants With Pain Control During Ambulation | Placebo | 100.0 | Percentage of participants | ||
| Percentage of Participants Without Severe Fracture-Site Pain During 24 Hours Prior to Visit | Teriparatide | 81.8 | Percentage of participants | ||
| Percentage of Participants Without Severe Fracture-Site Pain During 24 Hours Prior to Visit | Placebo | 92.9 | Percentage of participants | ||
| Percentage of Participants Without Severe Fracture-Site Pain During Weight Bearing | Teriparatide | 90.9 | Percentage of participants | ||
| Percentage of Participants Without Severe Fracture-Site Pain During Weight Bearing | Placebo | 84.6 | Percentage of participants | ||
| Percentage of Participants With Functional Evidence of Healing | Teriparatide | 76.9 | Percentage of participants | ||
| Percentage of Participants With Functional Evidence of Healing | Placebo | 66.7 | Percentage of participants | ||
| Percentage of Participants Able to Ambulate | Teriparatide | 76.9 | Percentage of participants | ||
| Percentage of Participants Able to Ambulate | Placebo | 93.3 | Percentage of participants | ||
| Percentage of Participants Who Regained Their Prefracture Ambulatory Status | Teriparatide | 47.1 | Percentage of participants | ||
| Percentage of Participants Who Regained Their Prefracture Ambulatory Status | Placebo | 62.5 | Percentage of participants | ||
| Mean Change From Baseline to 6 Months in Worst Fracture-Site Pain | Teriparatide | During ambulation ( n= 10, 13) | -1.6 | Standard Error 1.46 | Units on a scale |
| Mean Change From Baseline to 6 Months in Worst Fracture-Site Pain | Placebo | During ambulation ( n= 10, 13) | -1.3 | Standard Error 1.45 | Units on a scale |
| Mean Change From Baseline to 6 Months in Worst Fracture-Site Pain | Teriparatide | During 24 hours preceding visit (n= 10, 14) | -1.2 | Standard Error 1.27 | Units on a scale |
| Mean Change From Baseline to 6 Months in Worst Fracture-Site Pain | Placebo | During 24 hours preceding visit (n= 10, 14) | -1.4 | Standard Error 1.21 | Units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01473602/results